Showing 51-60 of 352 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-December-2026 | $900,000.00 |
| Clinical Translation of NICHE for pancreatic islet transplantation for T1D | Continuity Biosciences | Alessandro Grattoni | Cures | 01-March-2026 to 28-February-2030 | $2,675,316.00 |
| Type 1 Diabetes Consortium – New Onset Workstream | Critical Path Institute (C-Path) | Joseph Hedrick | Cures | 28-October-2022 to 31-December-2026 | $1,560,723.00 |
| IND Readiness Gap Analysis and Risk Assessment | Dark Horse Consulting | Amanda Mack | Cures | 15-June-2026 to 30-November-2026 | $80,325.05 |
| Broad Scope CMC, Non-Clinical, and Regulatory Support | Dark Horse Consulting | Nathan Manley | Cures | 01-September-2025 to 31-December-2026 | $85,000.00 |
| Pilot Testing a Digital Single Session Intervention for Diabetes Distress | Duke University | Max Roberts | Improving Lives | 01-October-2026 to 30-September-2027 | $110,000.00 |
| ACTin1 for DD: Developing and Testing a Digital Single Session Acceptance and Commitment Therapy Intervention for Type 1 Diabetes Distress | Duke University | Max Roberts | Improving Lives | 01-April-2026 to 31-March-2029 | $241,710.00 |
| Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling | Duke University | Rhonda Merwin | Improving Lives | 01-July-2022 to 30-June-2027 | $2,758,224.22 |
| Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells | East Tennessee State University | Anoop Arunagiri | Cures | 01-August-2025 to 31-July-2027 | $241,431.00 |
| Evaluating the Effectiveness and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 1 Diabetes | Emory University | Piaopiao Li | Improving Lives | 01-July-2025 to 30-June-2027 | $599,998.91 |